{
  "retracted": false,
  "timestamp": 1511136000000,
  "updates": [
    {
      "timestamp": 1585484432474,
      "identifier": {
        "doi": "10.1007/s12282-017-0815-7"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1007/s12282-017-0798-4"
  },
  "publisher": "Springer Science and Business Media LLC",
  "title": "Correction to: Phase I dose-finding study of eribulin and capecitabine for metastatic breast cancer: JBCRG-18 cape study"
}
